Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis - PubMed (original) (raw)
Review
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Bente Langdahl et al. Ther Adv Musculoskelet Dis. 2016 Dec.
Abstract
The adult skeleton is renewed by remodeling throughout life. Bone remodeling is a process where osteoclasts and osteoblasts work sequentially in the same bone remodeling unit. After the attainment of peak bone mass, bone remodeling is balanced and bone mass is stable for one or two decades until age-related bone loss begins. Age-related bone loss is caused by increases in resorptive activity and reduced bone formation. The relative importance of cortical remodeling increases with age as cancellous bone is lost and remodeling activity in both compartments increases. Bone modeling describes the process whereby bones are shaped or reshaped by the independent action of osteoblast and osteoclasts. The activities of osteoblasts and osteoclasts are not necessarily coupled anatomically or temporally. Bone modeling defines skeletal development and growth but continues throughout life. Modeling-based bone formation contributes to the periosteal expansion, just as remodeling-based resorption is responsible for the medullary expansion seen at the long bones with aging. Existing and upcoming treatments affect remodeling as well as modeling. Teriparatide stimulates bone formation, 70% of which is remodeling based and 20-30% is modeling based. The vast majority of modeling represents overflow from remodeling units rather than de novo modeling. Denosumab inhibits bone remodeling but is permissive for modeling at cortex. Odanacatib inhibits bone resorption by inhibiting cathepsin K activity, whereas modeling-based bone formation is stimulated at periosteal surfaces. Inhibition of sclerostin stimulates bone formation and histomorphometric analysis demonstrated that bone formation is predominantly modeling based. The bone-mass response to some osteoporosis treatments in humans certainly suggests that nonremodeling mechanisms contribute to this response and bone modeling may be such a mechanism. To date, this has only been demonstrated for teriparatide, however, it is clear that rediscovering a phenomenon that was first observed more half a century ago will have an important impact on our understanding of how new antifracture treatments work.
Keywords: bisphosphonates; bone modeling; bone remodeling; denosumab; osteoporosis; romosozumab; teriparatide.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
Figure 1.
The theoretical contribution of bone remodeling and modeling to the change in hip bone mineral density (BMD) in postmenopausal women with or without existing and upcoming treatments for osteoporosis. BPs, bisphosphonates [Black et al. 2015; Miller et al. 2012]; Dmab, denosumab [Bone et al. 2013]; No Tx, no treatment; Odn, odanacatib [Langdahl et al. 2012]; Romo, romosozumab [McClung et al. 2014a, b]; SERMs, selective estrogen receptor modulators [Silverman et al. 2012]; TPTD, teriparatide [Neer et al. 2001].
Similar articles
- Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E. Seeman E. Osteoporos Int. 2003;14 Suppl 3:S2-8. doi: 10.1007/s00198-002-1340-9. Epub 2003 Mar 19. Osteoporos Int. 2003. PMID: 12730770 Review. - Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study.
Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Melby TE, Ruff VA. Dempster DW, et al. J Bone Miner Res. 2018 Feb;33(2):298-306. doi: 10.1002/jbmr.3309. Epub 2017 Nov 15. J Bone Miner Res. 2018. PMID: 29024120 Clinical Trial. - Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.
Ramchand SK, Seeman E. Ramchand SK, et al. Handb Exp Pharmacol. 2020;262:423-450. doi: 10.1007/164_2020_354. Handb Exp Pharmacol. 2020. PMID: 32232792
Cited by
- Europium-Containing Nanospheres for Treating Ovariectomy-Induced Osteoporosis: Targeted Bone Remodeling and Macrophage Polarization Modulation.
Wang YC, Cai MT, Chen MH, Tung FI, Chen MH, Liu TY. Wang YC, et al. Int J Nanomedicine. 2024 Oct 5;19:10145-10163. doi: 10.2147/IJN.S472253. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39386058 Free PMC article. - Impact of anti-fracture medications on bone material and strength properties: a systematic review and meta-analysis.
Sharma S, Shankar V, Rajender S, Mithal A, Rao SD, Chattopadhyay N. Sharma S, et al. Front Endocrinol (Lausanne). 2024 Aug 27;15:1426490. doi: 10.3389/fendo.2024.1426490. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39257899 Free PMC article. - Effects of Cannabidiol on Bone Quality in Ovariectomized Rats.
de Oliveira AC, Macedo AP, Shimano AC. de Oliveira AC, et al. Calcif Tissue Int. 2024 Sep 9. doi: 10.1007/s00223-024-01281-6. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39245783 - Microbial Tryptophan Metabolites Ameliorate Ovariectomy-Induced Bone Loss by Repairing Intestinal AhR-Mediated Gut-Bone Signaling Pathway.
Chen C, Cao Z, Lei H, Zhang C, Wu M, Huang S, Li X, Xie D, Liu M, Zhang L, Chen G. Chen C, et al. Adv Sci (Weinh). 2024 Sep;11(36):e2404545. doi: 10.1002/advs.202404545. Epub 2024 Jul 23. Adv Sci (Weinh). 2024. PMID: 39041942 Free PMC article. - Does Swimming Exercise Impair Bone Health? A Systematic Review and Meta-Analysis Comparing the Evidence in Humans and Rodent Models.
Freitas L, Bezerra A, Boppre G, Amorim T, Fernandes RJ, Fonseca H. Freitas L, et al. Sports Med. 2024 Sep;54(9):2373-2394. doi: 10.1007/s40279-024-02052-x. Epub 2024 Jun 20. Sports Med. 2024. PMID: 38900358
References
- Allen M., Burr D. (2008) Skeletal microdamage: less about biomechanics and more about remodeling. Clin Rev Bone Miner Metabol 6: 24–30.
- Balena R., Shih M., Parfitt A. (1992) Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women. J Bone Miner Res 7: 1475–1482. - PubMed
- Banks W., Jr, Epling G., Kainer R., Davis R. (1968a) Antler growth and osteoporosis. I. Morphological and morphometric changes in the costal compacta during the antler growth cycle. Anat Rec 162: 387–398. - PubMed
- Banks W., Jr, Epling G., Kainer R., Davis R. (1968b) Antler growth and osteoporosis. II. Gravimetric and chemical changes in the costal compacta during the antler growth cycle. Anat Rec 162: 399–406. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources